Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
314728-85-3CCC(=O)N1CCN(C(=O)c2ccccc2)CC1DGOWDUFJCINDGI-UHFFFAOYSA-N314728-85-3DTXSID10400996CHEMBL309176Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
BeschreibungSunifiram (DM235, CAS Number: 314728-85-3) is a novel pyrrolidone nootropic drug that was developed by the Gualtieri research group in 2000. It has a similar structure to piracetam, but it is not classified as a racetam drug due to the breaking of its pyrrolidone backbone. Sunifiram was originally developed to treat neurodegenerative disorders, such as Alzheimer's disease. Compared to piracetam, its anti-amnesiac activity is several orders of magnitude higher on a per-weight basis. The drugs can be helpful in the treatment of neurodegenerative disorders like Alzheimer’s, Parkinson’s, multiple sclerosis, schizophrenia, and attention-deficit hyperactivity disorders.
VerwendenSunifiram is a potent nootropic agent that provides a range of cognitive benefits. Its ability to improve concentration, focus, and mental clarity can greatly aid in the management and completion of cognitive tasks. In addition, it has been shown to enhance motivation, which is essential for achieving cognitive goals.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…